Medicus Pharma Ltd.
MDCX
$0.30
-$0.04-10.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.50% | 9.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.12% | 11.52% | |||
| Operating Income | -16.12% | -11.52% | |||
| Income Before Tax | 28.03% | -238.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.03% | -238.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -- | |||
| Net Income | 28.03% | -238.98% | |||
| EBIT | -16.12% | -11.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 27.92% | -159.88% | |||
| Normalized Basic EPS | -28.47% | -49.48% | |||
| EPS Diluted | -44.53% | -159.88% | |||
| Normalized Diluted EPS | -28.47% | -49.48% | |||
| Average Basic Shares Outstanding | -0.16% | 30.43% | |||
| Average Diluted Shares Outstanding | -0.16% | 30.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||